A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma
Journal article published in 2015 by
A. K. Nowak,
A. M. Cook,
A. M. McDonnell,
M. J. Millward,
J. Creaney,
R. J. Francis,
A. Hasani,
A. Segal,
A. W. Musk,
B. A. Turlach 
,
M. J. McCoy,
B. W. S. Robinson,
R. A. Lake
,
M. J. McCoy,
B. W. S. Robinson,
R. A. Lake
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 